Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma

by Caitlin M. Brumfiel, MS, Meera H. Patel, BS, Bashar Aqel, MD, Michael Lehrer, MD, Samir H. Patel, MD, Mahesh Seetharam, MD
Published 2021-08-01

A Critical Review of LET-Based Intensity-Modulated Proton Therapy Plan Evaluation and Optimization for Head and Neck Cancer Management

by Wei Deng, PhD, Yunze Yang, PhD, Chenbin Liu, PhD, Martin Bues, PhD, Radhe Mohan, PhD, William W. Wong, MD, Robert H. Foote, MD, Samir H. Patel, MD, Wei Liu, PhD
Published 2021-06-01

Understanding American Indian Perceptions Toward Radiation Therapy

by Samir H. Patel MD, Sasha Ebrahimi PhD, Donald W. Northfelt MD, Timothy E. Mathews FNP-BC, Farhia M. Omar MPH, Erika D. Martinez MBA, Todd A. DeWees PhD, Janet M. Okamoto PhD
Published 2020-07-01

Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer

by Nathan Y. Yu, MD, Aditya Khurana, BS, Daniel J. Ma, MD, Michelle A. Neben-Wittich, MD, Michael A. Golafshar, MS, Lisa A. McGee, MD, Jean-Claude M. Rwigema, MD, Robert L. Foote, MD, Samir H. Patel, MD
Published 2021-06-01

A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors

by Mauricio E. Gamez, M.D., Samir H. Patel, M.D., Lisa A. McGee, M.D., Terence T. Sio, M.D., Mark McDonald, M.D., Jack Phan, M.D., Ma M.D. Daniel J., Robert L. Foote, M.D., Jean-Claude M. Rwigema, M.D.
Published 2021-06-01

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors

by Nathan Y. Yu, MD, Mauricio E. Gamez, MD, William F. Hartsell, MD, Henry K. Tsai, MD, George E. Laramore, MD, PhD, Gary L. Larson, MD, Charles B. Simone, II, MD, Carl Rossi, MD, Sanford R. Katz, MD, Matthew R. Buras, MS, Michael A. Golafshar, MS, Carlos E. Vargas, MD, Samir H. Patel, MD
Published 2019-10-01

PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors

by Alexander Lin, MD, John H. C. Chang, MD, Ryan S. Grover, MD, Frank J. P. Hoebers, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR, Samir H. Patel, MD, Juliette Thariat, MD, PhD, David J. Thomson, MA, MD, FACR, Johannes A. Langendijk, MD, PhD, Steven J. Frank, MD, on behalf of the International Particle Therapy Co-operative Group (PTCOG) Head and Neck Subcommittee
Published 2021-06-01

Oncologic Outcomes for Head and Neck Skin Malignancies Treated with Protons

by Jidapa Bridhikitti, MD, Jason K. Viehman, W. Scott Harmsen, Adam C. Amundson, Satomi Shiraishi, PhD, Daniel W. Mundy, PhD, Jean-Claude M. Rwigema, MD, Lisa A. McGee, MD, Samir H. Patel, MD, David M. Routman, MD, Scott C. Lester, MD, Michelle A. Neben-Wittich, MD, Yolanda I. Garces, MD, Daniel J. Ma, MD, Robert L. Foote, MD
Published 2021-06-01

The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial

by Mike Hernandez, MS, J. Jack Lee, PhD, Beow Y. Yeap, ScD, Rong Ye, MS, Robert L. Foote, MD, Paul Busse, MD, PhD, Samir H. Patel, MD, Roi Dagan, MD, James Snider, MD, Nasiruddin Mohammed, MD, MBA, Alexander Lin, MD, Pierre Blanchard, MD, PhD, Scott B. Cantor, PhD, Menna Y. Teferra, MS, Kate Hutcheson, PhD, Pablo Yepes, PhD, Radhe Mohan, PhD, Zhongxing Liao, MD, Thomas F. DeLaney, MD, Steven J. Frank, MD
Published 2021-03-01

The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers

by Jaden D. Evans, MD, Riley H. Harper, BS, Molly Petersen, MS, William S. Harmsen, MS, Aman Anand, PhD, Ashley Hunzeker, CMD, Noelle C. Deiter, RTT, Heather Schultz, CMD, Krishan R. Jethwa, MD, Scott C. Lester, MD, David M. Routman, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben-Wittich, MD, Nadia N. Laack, MD, Chris J. Beltran, PhD, Samir H. Patel, MD, Lisa A. McGee, MD, Jean-Claude M. Rwigema, MD, Daniel W. Mundy, PhD, Robert L. Foote, MD
Published 2020-08-01

Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer

by Grace L. Smith, MD, PhD, MPH, Shuangshuang Fu, PhD, Matthew S. Ning, MD, MPH, Diem-Khanh Nguyen, BA, Paul M. Busse, MD, PhD, Robert L. Foote, MD, Adam S. Garden, MD, Gary B. Gunn, MD, Clifton D. Fuller, MD, PhD, William H. Morrison, MD, Gregory M. Chronowski, MD, Shalin J. Shah, MD, Lauren L. Mayo, MD, Jack Phan, MD, PhD, Jay P. Reddy, PhD, James W. Snider III, MD, Samir H. Patel, MD, Sanford R. Katz, MD, Alexander Lin, MD, Nasiruddin Mohammed, MD, Roi Dagan, MD, MS, Nancy Y. Lee, MD, David I. Rosenthal, MD, Steven J. Frank, MD
Published 2021-06-01